cover image - Pharmacology for Health Professionals, seventh edition - E-Book VBK, 7th Edition
ISBN: 9780729599849
Copyright: 2027
Page Count: 1060
Imprint: Elsevier
List Price: $87.99

Pharmacology for Health Professionals, seventh edition - E-Book VBK, 7th Edition

by Andrew Rowland, PhD, BSc (Hons), Shaunagh Darroch, BSc, MPharm,GradCertAcaPrac, Mary Bushell, BPharm (Hons), GCLTHE, PhD and Voula Gaganis, PhD, Med (HighEd), BAppSc

Elsevier eBook on VitalSource

cover image - Pharmacology for Health Professionals, seventh edition - E-Book VBK, 7th Edition
ISBN: 9780729599849
Copyright: 2027
Page Count: 1060
Imprint: Elsevier
List Price: $87.99

$87.99

Or $0.00 with a valid access code
Not Yet Available
Coming Soon!
Expected availability date: 10-15-2026

Pharmacology for Health Professionals provides a clinically grounded introduction to pharmacology, guiding students from foundational principles through to in-depth exploration of drug actions across major body systems and their application in treating common pathological conditions in the Australian and New Zealand context.

Designed for nursing, pharmacy and allied health students, this trusted text takes an integrated, practice-focused approach that links pharmacological mechanisms to real-world clinical care. Clear, concept-driven explanations build understanding of complex physiological processes while reinforcing safe, patient-centred and evidence-based use of medicines.

Aligned with contemporary Australasian practice, the text incorporates medicines policy, public health perspectives and interprofessional collaboration, preparing graduates for practice in dynamic healthcare environments. Particular attention is given to medication safety, polypharmacy and rational medicines use, especially in aged care and other complex patient populations.

A carefully scaffolded chapter structure supports learning progression and enhances engagement with challenging content.

New to this edition

  • Expanded coverage of aged care and special populations
  • Enhanced focus on medication safety and polypharmacy
  • Significant revision of foundational clinical, ethical and legal content
  • Major updates to cancer therapy, antimicrobial chemotherapy and resistance, obesity pharmacotherapy and vaccinations
  • Updated epidemiological data, clinical guidelines and emerging therapeutics
  • New and revised Critical Thinking Scenarios, with additional resources available via Evolve and ClinicalKey

Comprehensive, contemporary and accessible, Pharmacology for Health Professionals equips students with the knowledge and confidence to apply pharmacology safely and effectively.

    • Critical Thinking Scenarios opening each chapter establish clinical context
    • Clinical Focus boxes address common medication issues
    • Key Points summaries consolidate essential concepts
    • Drug Monographs and Drugs at a Glance tables provide clear, rapid reference
    • End-of-chapter review questions integrate theory and practice
    • Comprehensive art and expanded humanoid models illustrate core pharmacological mechanisms
    • Structured ‘chunking’ of content supports comprehension and retention


    Additional instructor resources

    • Solutions to end-of-chapter review questions
    • Additional Critical Thinking Scenarios + model answers
    • Additional Clinical Interest boxes
    • PowerPoint presentation
  • UNIT 1
    1 Drugs and medicines
    2 Clinical, ethical and legal foundations of pharmacotherapy

    UNIT 2
    3 Molecular drug targets and pharmacodynamics
    4 Drug absorption, distribution, metabolism and excretion
    5 Pharmacokinetics and dosing regimens
    6 Precision medicine
    7 Adverse drug reactions and drug interactions

    UNIT 3
    8 Drugs affecting cholinergic transmission
    9 Drugs affecting noradrenergic transmission

    UNIT 4
    10 Drugs affecting cardiac function
    11 Drugs affecting vascular smooth muscle
    12 Lipid-lowering drugs
    13 Drugs affecting thrombosis and haemostasis
    14 Drugs affecting the haemopoietic system

    UNIT 5
    15 Drugs used in respiratory disorders

    UNIT 6
    16 Drugs affecting the upper and lower gastrointestinal tract

    UNIT 7
    17 Drugs affecting the kidney and bladder

    UNIT 8
    18 Central nervous system overview and anaesthetics
    19 Analgesics
    20 Antianxiety, sedative and hypnotic drugs
    21 Antiepileptic drugs
    22 Psychotropic agents
    23 Central nervous system stimulants
    24 Drugs for neurodegenerative disorders and headache
    25 Drug dependence and social pharmacology

    UNIT 9
    26 The neuroendocrine system and pituitary gland
    27 The thyroid gland, the parathyroid glands and bone disorders
    28 The endocrine pancreas and diabetes mellitus
    29 The adrenal cortex and corticosteroids

    UNIT 10
    30 Drugs affecting the female reproductive system
    31 Drugs affecting the male reproductive system

    UNIT 11
    32 Principles of cancer therapy
    33 Antineoplastic drugs

    UNIT 12
    34 Anti-inflammatory and immunomodulating drugs

    UNIT 13
    35 Overview of antimicrobial chemotherapy and antibiotic resistance
    36 Antibacterial drugs
    37 Antifungal and antiviral drugs
    38 Antiprotozoal, antimycobacterial and anthelmintic drugs

    UNIT 14
    39 Drugs affecting the skin
    40 Drugs affecting the eye and ear
    41 Drugs in aged care
    42 Pharmacotherapy of obesity
    43 Vaccinations
    44 Complementary medicines
  • Andrew Rowland, PhD, BSc (Hons), Senior Lecturer, Department of Clinical
    Pharmacology, College of Medicine
    and Public Health, Flinders University,
    Adelaide, South Australia, Australia, Shaunagh Darroch, BSc, MPharm,GradCertAcaPrac, Pharmacologist, Melbourne, Victoria,Australia, Mary Bushell, BPharm (Hons), GCLTHE, PhD and Voula Gaganis, PhD, Med (HighEd), BAppSc, Associate Professor physiology, College of Medicine and Public Health, c/o Flinders Medical Centre, Flinders University, Sturt Road, Bedford Park, South Australia
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • No information about nonvisual reading is available
    • Conformance
      • No information is available
    • Navigation
      • Table of contents to all chapters of the text via links
      • Page list to go to pages from the print source version
    • Rich Content
      • No information is available
    • Hazards
      • No information is available
    • Product Content
      • No information is available
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.

$87.99

Or $0.00 with a valid access code
Not Yet Available
Coming Soon!
Expected availability date: 10-15-2026